SXTC
China SXT Pharmaceuticals, Inc.
$2.28
%
Analyst Rating:N/A

Stock Details

CEO

Feng Zhou

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Full Time Employees

75

Address

178 Taidong Road North, Taizhou, 225300

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

Income Statement  

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for China SXT Pharmaceuticals, Inc.  $2.28

EPS

Revenue

Congress Tracker 

Insider Trading of Key Employees

Financial News: SXTC